Learn about vasculitis, its causes and risk factors, types, treatment options, and more. An autoimmune reaction happens when the immune system attacks healthy cells in the body. This can lead to ...

If you have symptoms of vasculitis, see your healthcare provider as soon as possible. If left untreated, this condition can cause life-threatening complications. Treatment options for vasculitis vary ...

Are autoimmune diseases fatal? Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system ...

vasculitis is not universally present at the microscopic level. Although some patients with scleritis respond well to treatment with NSAIDs, aggressive systemic therapy is often required to obtain ...

A new study published in the Journal of American Medical Association showed that rare instances of noninfectious intraocular ...

Primary central nervous system (CNS) vasculitis is a rare, frequently misdiagnosed condition that affects the brain and spinal cord and is characterized by a variety of neurologic symptoms at ...

Also called Raynaud’s disease or Raynaud’s phenomenon, this condition causes fingers and toes to be very sensitive to cold or ...

The approval of another treatment in EGPA is welcome news to ... executive director of the Vasculitis Foundation, in a press release on September 18. "Patients often rely on long-term oral ...

so that more vasculitis patients can benefit. He said: "This research answers the question: can we monitor the activity of the disease once treatment has started? "Can we say, after six months ...

Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

A team led by Prof Aman Sharma at PGI has published the first-ever Indian guidelines for treating ANCA-associated vasculitis, ...

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...